Ardent Health, Inc.

Listed Company

ARDTCIK 0001756655NYSEAcceleratedServices-General Medical & Surgical Hospitals, NecDelawareFY ends Dec 31

Period

FY 2025

Revenue

$6.32B

Net Income

$135.81M

Total Assets

$5.29B

Equity

$1.29B

Shares Out

143.35M

Op. Cash Flow

$470.51M

ARDT$10.14−12.36% · past yearDBEQ Basic

Daily closing prices

Business

Ardent Health, Inc. operates acute care hospitals and integrated ambulatory care sites across eight mid-sized urban markets in six states. The company provides general and specialty inpatient and outpatient services including internal medicine, surgery, cardiology, oncology, and emergency care through hospitals, clinics, surgery centers, urgent care facilities, and telehealth. Ardent operates through a differentiated joint-venture model with academic medical centers, not-for-profit health systems, and physicians.

Summary from 10-K filed 2026-03-16

Financials

Consolidated Statement of Income

Year Ended · In millions, except per-share amounts

Concept	FY 2025 2025-12-31	FY 2024 2024-12-31	FY 2023 2023-12-31	FY 2022 2022-12-31
Total revenue	6,324	5,966	5,409	5,130
Salaries and benefits	2,658	2,535	2,384	2,412
Professional fees	1,193	1,097	980	736
Supplies	1,083	1,033	993	955
Other operating expenses	647	496	452	464
Government stimulus income	0	0	−9	−17
Interest expense	55	66	74	—
Depreciation and amortization	156	146	141	138
Loss on extinguishment and modification of debt	7	3	0	0
Other non-operating gains	−23	−26	−2	−19
Total operating expenses	6,038	5,603	5,258	4,818
Income before income taxes	286	363	152	311
Income tax expense	56	63	23	46
Net income	230	300	129	265
Net income attributable to noncontrolling interests	94	89	75	76
Net income attributable to Ardent Health, Inc.	136	210	54	189
Net income per common share, basic (in USD per share)	0.96	1.59	0.43	1.5
Net income per common share, diluted (in USD per share)	0.96	1.58	0.43	1.5
Weighted average number of common shares, basic (in shares)	141	132	126	126
Weighted average number of common shares, diluted (in shares)	141	133	126	126

Consolidated Balance Sheet

As of · In millions, except per-share amounts

Concept	FY 2025 2025-12-31	FY 2024 2024-12-31	FY 2023 2023-12-31	FY 2022 2022-12-31	FY 2021 2021-12-31
Cash and cash equivalents	710	557	438	—	—
Accounts receivable	686	743	775	—	—
Inventories	119	115	105	—	—
Prepaid expenses	113	114	77	—	—
Other current assets	432	304	222	—	—
Total current assets	2,059	1,833	1,618	—	—
Property and equipment, net	936	862	—	—	—
Goodwill	879	852	845	845	—
Other intangible assets	89	77	77	—	—
Deferred income taxes	7	12	32	—	—
Other assets	112	143	147	—	—
Total assets	5,290	4,956	4,732	—	—
Current installments of long-term debt	23	9	19	—	—
Accounts payable	458	401	475	—	—
Accrued salaries and benefits	296	295	268	—	—
Other accrued expenses and liabilities	269	240	233	—	—
Total current liabilities	1,047	945	994	—	—
Long-term debt, less current installments	1,076	1,086	1,168	—	—
Long-term operating lease liability	1,165	1,141	—	—	—
Self-insured liabilities	241	227	244	—	—
Other long-term liabilities	77	35	76	—	—
Total liabilities	3,605	3,434	3,649	—	—
Commitments and contingencies (see Note 13)	—	—	—	—	—
Redeemable noncontrolling interests	−1	1	7	11	—
Preferred stock, par value $0.01 per share; 50,000,000 shares authorized; no shares issued and outstanding	0	0	0	—	—
Common stock, par value $0.01 per share; 750,000,000 shares authorized; 142,864,171 and 142,747,818 shares issued and outstanding as of December 31, 2025 and 2024, respectively	1	1	0	—	—
Additional paid-in capital	788	754	0	—	—
Accumulated other comprehensive (loss) income	−4	10	19	—	—
Retained earnings	502	366	155	—	—
Equity attributable to Ardent Health, Inc.	1,288	1,131	671	—	—
Noncontrolling interests	398	390	404	—	—
Total equity	1,686	1,521	1,075	1,040	978
Total liabilities and equity	5,290	4,956	4,732	—	—

Consolidated Statement of Cash Flows

Year Ended · In millions, except per-share amounts

Concept	FY 2025 2025-12-31	FY 2024 2024-12-31	FY 2023 2023-12-31	FY 2022 2022-12-31
Depreciation and amortization	156	146	141	138
Loss on extinguishment and modification of debt	515,000	2	0	0
Amortization of deferred financing costs and debt discounts	4	5	5	6
Deferred income taxes	44	24	4	46
Equity-based compensation	39	18	904,000	611,000
(Income) loss from non-consolidated affiliates	−1	6	−2	−8
Accounts receivable	59	40	−181	−17
Inventories	−3	−9	2	5
Prepaid expenses and other current assets	−122	−136	−37	8
Accounts payable and other accrued expenses and liabilities	62	−104	137	14
Accrued salaries and benefits	686,000	28	23	−19
Net cash provided by operating activities	471	315	222	−38
Investment in acquisitions, net of cash acquired	−3	−36	0	0
Purchases of property and equipment	−212	−188	−137	−151
Other	179,000	−2	−575,000	−9
Net cash used in investing activities	−214	−220	−138	47
Proceeds from initial public offering, net of underwriting discounts and commissions	0	209	0	0
Proceeds from revolving line of credit	0	0	125	0
Proceeds from insurance financing arrangements	16	11	25	4
Proceeds from long-term debt	0	4	7	878,000
Payments of principal on revolving line of credit	0	0	−125	0
Payments of principal on insurance financing arrangements	−15	−10	−23	−4
Payments of principal on long-term debt	−8	−108	−14	−17
Debt issuance costs	−3	−2	0	0
Payments of initial public offering costs	0	−10	0	−2
Distributions to noncontrolling interests	−88	−73	−64	−69
Redemption of equity attributable to noncontrolling interests	0	0	−26	0
Other	−5	5	−7	−10
Net cash (used in) provided by financing activities	−103	25	−102	−270
Net increase (decrease) in cash and cash equivalents	153	119	−19	−262
Non-cash purchases of property and equipment	16	9	16	10
Offering costs not yet paid	0	330,000	0	0
Income tax payments, net	37	42	19	56

Filings

Filing historySign up free to browse every 10-K, 10-Q, 8-K, and proxy this filer has submitted to the SEC.Sign up free · Upgrade to Pro

Material Events

Material EventsTrack every 8-K filing and material event — AI-summarized, timelined, and alertable.Sign up free · Upgrade to Pro

Insiders

Insider ActivitySee executive buy/sell windows and insider trade activity over rolling 30/90/365-day windows.Sign up free · Upgrade to Pro

Institutional Holders

Institutional HoldersSee which funds hold this stock and track position changes quarter over quarter.Sign up free · Upgrade to Pro

Frequently asked questions

What is Ardent Health, Inc.'s CIK number?

Ardent Health, Inc.'s SEC CIK number is 0001756655 (1756655). The CIK (Central Index Key) is the permanent identifier the SEC assigns to every EDGAR filer — unlike a ticker symbol, it never changes.

Where can I find Ardent Health, Inc.'s SEC filings?

All of Ardent Health, Inc.'s EDGAR filings — 10-K annual reports, 10-Q quarterly reports, 8-K material events, and insider transactions — are listed on this page, sourced live from SEC EDGAR.

When did Ardent Health, Inc. last report earnings?

Ardent Health, Inc. (ARDT) most recently filed an earnings 8-K with the SEC on May 5, 2026, furnishing its results under Item 2.02 (Results of Operations and Financial Condition). The earnings press release is attached to that filing (accession 0001628280-26-030552). This is Ardent Health, Inc.'s most recent earnings filing of record — not a forecast of its next earnings date.

What is Ardent Health, Inc.'s most recent earnings 8-K?

Ardent Health, Inc.'s latest earnings 8-K (Item 2.02) was filed May 5, 2026 under accession 0001628280-26-030552. It carries the quarterly or annual earnings press release — the earliest official, SEC-filed version of the results.

View Ardent Health, Inc.'s latest earnings 8-K →
Look up any company's CIK number →